Issue of Equity
Zotefoams plc has conditionally agreed to allot and issue 400,000 new ordinary shares at par value to the Zotefoams plc 2007 Employee Benefit Trust on May 13, 2026, to satisfy future share incentive awards. Following this issuance, the Trust will hold 464,355 ordinary shares, representing approximately 0.94 percent of the enlarged issued share capital. The company expects admission of these new shares to the Official List and the London Stock Exchange's main market to become effective on the same date, at which point the total number of ordinary shares in issue will be 49,646,234.
Select text to share a quote on X · sign in to keep highlights & notes in your ZTF notes
7 May 2026 - Zotefoams plc (LSE: ZTF) announces that it has conditionally agreed to allot and issue 400,000 new ordinary shares of five pence each in the capital of the Company ("Ordinary Shares") on 13 May 2026, (the "New Shares").
The New Shares, which will rank pari passu with the existing Ordinary Shares in issue, will be allotted and issued to the Zotefoams plc 2007 Employee Benefit Trust (the "EBT") at the par value of five pence each in order to satisfy future exercises of awards under the Group's share incentive schemes.
The EBT will thereafter hold a total of 464,355 Ordinary Shares, representing approximately 0.94 percent of the enlarged issued share capital of the Company.
Applications have been made to the Financial Conduct Authority (the "FCA") for the admission of the New Shares to the equity shares (commercial companies) category of the Official List of the FCA and to London Stock Exchange plc for admission to trading of the New Shares on its main market for listed securities (together, "Admission"). Admission is expected to become effective at 8.00 a.m. on 13 May 2026
The allotment and issue of the New Shares are conditional upon Admission becoming effective.
Following Admission, the Company will have 49,646,234 Ordinary Shares in issue. There are no Ordinary Shares held in treasury. Therefore, following Admission the total number of voting rights in the Company will be 49,646,234 and this figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their voting rights interest, or a change to that interest, in the Company under the FCA's Disclosure Guidance and Transparency Rules.
AZOTE®, ZOTEK®, ReZorce® and T-FIT® are registered trademarks of Zotefoams plc
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.